PODCAST

Gastroenterology and Hepatology

ReachMD

science & medicine medicine

All Episodes

00:00:00

Navigating Treatment Paths: Selection and Sequencing...

Gastroenterology and Hepatology ·

2024/04/25

Host: Yelena Janjigian, MD Host: Samuel J. Klempner, MD The therapeutic landscape for gastric and gastroesophageal junction (G/GEJ) cancer is rapidly evolving, with biomarkers directing treatment selection. Recent evidence suggests that the combination of HER2-targeted therapies and immune checkpoint inhibitors has synergistic effects, highlighting the importance of the most recent clinical data regarding first-line treatments for advanced or metastatic G/GEJ cancers and the

00:00:00

Optimizing Treatment of Metastatic G/GEJ Cancers:...

Gastroenterology and Hepatology ·

2024/04/25

00:00:00

How Can a Multidisciplinary Team Optimize Management...

Gastroenterology and Hepatology ·

2024/04/25

Host: Yelena Janjigian, MD The therapeutic landscape for gastric and gastroesophageal junction (G/GEJ) cancer is rapidly evolving, with biomarkers directing treatment selection. Recent evidence suggests that the combination of HER2-targeted therapies and immune checkpoint inhibitors has synergistic effects, highlighting the importance of the most recent clinical data regarding first-line treatments for advanced or metastatic G/GEJ cancers and the differentiation between HER2-positive

00:00:00

Managing Extraintestinal Manifestations in IBD

Gastroenterology and Hepatology ·

2024/04/15

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Katherine Falloon, MD Extraintestinal manifestations (EIMs) that occur in inflammatory bowel disease (IBD) are almost any manifestation that occur outside the gastrointestinal tract. And patients with Crohn’s disease or ulcerative colitis are at an increased risk for developing these manifestations. So to review EIMs in IBD and discuss the importance of a multidisciplinary approach, Dr. Peter Buch is joined by Dr. Katherine Falloon,

00:00:00

Tackling the Unmet Need HEad On—What Does HE Look Like?

Gastroenterology and Hepatology ·

2024/03/22

Host: Arun B. Jesudian, MD Presenting a major burden on our healthcare system, hepatic encephalopathy (HE) is a neurologic disorder that frequently affects individuals with chronic and acute liver disease. Characterized by a broad range of neurologic and psychological symptoms, including cognitive impairment, disorientation, sleep disturbances, and mood or personality changes, as liver disease progresses, the symptoms of HE tend to worsen and can lead to coma and death if left

00:00:00

HElp! AASLD Guidelines Related to Diagnosis of HE

Gastroenterology and Hepatology ·

2024/03/22

Host: Robert Rahimi, MD, MSCR Presenting a major burden on our healthcare system, hepatic encephalopathy (HE) is a neurologic disorder that frequently affects individuals with chronic and acute liver disease. Characterized by a broad range of neurologic and psychological symptoms, including cognitive impairment, disorientation, sleep disturbances, and mood or personality changes, as liver disease progresses, the symptoms of HE tend to worsen and can lead to coma and death if left

00:00:00

West HavEn Criteria—Meaningfulness Into Clinical...

Gastroenterology and Hepatology ·

2024/03/22

00:00:00

Collaboration and Management of HE: Establishing...

Gastroenterology and Hepatology ·

2024/03/22

Host: Arun B. Jesudian, MD Host: Robert Rahimi, MD, MSCR Presenting a major burden on our healthcare system, hepatic encephalopathy (HE) is a neurologic disorder that frequently affects individuals with chronic and acute liver disease. Characterized by a broad range of neurologic and psychological symptoms, including cognitive impairment, disorientation, sleep disturbances, and mood or personality changes, as liver disease progresses, the symptoms of HE tend to worsen and can lead

00:00:00

HEar My Needs: Enhancing the Patient and Provider...

Gastroenterology and Hepatology ·

2024/03/22

Host: Robert Rahimi, MD, MSCR Host: Arun B. Jesudian, MD Presenting a major burden on our healthcare system, hepatic encephalopathy (HE) is a neurologic disorder that frequently affects individuals with chronic and acute liver disease. Characterized by a broad range of neurologic and psychological symptoms, including cognitive impairment, disorientation, sleep disturbances, and mood or personality changes, as liver disease progresses, the symptoms of HE tend to worsen and can lead

00:00:00

Equitable HEalth for All: Improving Care for...

Gastroenterology and Hepatology ·

2024/03/22

Host: Patricia P. Bloom, MD Host: Robert Rahimi, MD, MSCR Presenting a major burden on our healthcare system, hepatic encephalopathy (HE) is a neurologic disorder that frequently affects individuals with chronic and acute liver disease. Characterized by a broad range of neurologic and psychological symptoms, including cognitive impairment, disorientation, sleep disturbances, and mood or personality changes, as liver disease progresses, the symptoms of HE tend to worsen and can lead

00:00:00

How Do I Prevent Future Hospital Visits due to HE?

Gastroenterology and Hepatology ·

2024/03/22

Host: Patricia P. Bloom, MD Presenting a major burden on our healthcare system, hepatic encephalopathy (HE) is a neurologic disorder that frequently affects individuals with chronic and acute liver disease. Characterized by a broad range of neurologic and psychological symptoms, including cognitive impairment, disorientation, sleep disturbances, and mood or personality changes, as liver disease progresses, the symptoms of HE tend to worsen and can lead to coma and death if left

00:00:00

The Unmet Need for HE Therapy in the African American...

Gastroenterology and Hepatology ·

2024/03/22

00:00:00

New Uses for Old Drugs: Insights on a Treatment...

Gastroenterology and Hepatology ·

2023/03/07

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: W. Frank Peacock, MD For patients with opioid-induced constipation (OIC), can Narcan play a role in finding a new treatment option? Dr. Charles Turck is joined by Dr. Frank Peacock from the Baylor College of Medicine to explore key data on the role of methylnaltrexone in the treatment of OIC.

00:00:00

Crohn's & Colitis Congress 2022: Looking Back &...

Gastroenterology and Hepatology ·

2022/04/21

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Peter D. Higgins, MD, PhD What were some of the key takeaways from the 2022 Crohn's & Colitis Congress, and what's in store for next year’s conference? Hear from the incoming 2023 Congress Chair Dr. Peter D. Higgins.

00:00:00

Crohn's & Colitis Congress 2022: Combating Challenges...

Gastroenterology and Hepatology ·

2022/04/08

Host: Jennifer Caudle, DO Guest: Ashish S. Patel, MD Treating IBD in our pediatric patients can be challenging, which is why creating a strong partnership between care teams and patients’ families is key. Fortunately, that was a central focus of the 2022 Crohn's & Colitis Congress, so to catch the latest updates and strategies for improving IBD care for pediatric patients, tune in to hear Dr. Jennifer Caudle speak with Dr. Ashish Patel.

00:00:00

Crohn's & Colitis Congress 2022: Improving Moderate...

Gastroenterology and Hepatology ·

2022/04/01

Host: Jennifer Caudle, DO Guest: Alan C. Moss, MD, FACG, FEBG, AGAF, FRCPI When patients with moderate ulcerative colitis fail first-line therapy, it's important to know what to do next. And speaking with your patients about their risks and preferences is key. Join us as Dr. Alan Moss shares highlights from his presentation at the 2022 Crohn's & Colitis Congress on treatment considerations for patients with moderate ulcerative colitis.

00:00:00

Endoscopic & Histological Assessment, Correlation, &...

Gastroenterology and Hepatology ·

2021/06/08

Guest: Jordan E. Axelrad, MD, MPH Endoscopic and Histological Assessment, Correlation, and Relapse in Clinically Quiescent Ulcerative Colitis (MARQUEE) Mark T Osterman, Frank I Scott, Franz F Fogt, Erin D Gilroy, Susan Parrott, Joseph Galanko, Raymond Cross, Alan Moss, Hans H Herfarth, Peter D R Higgins Abstract Objective: It is difficult to predict relapse in quiescent ulcerative colitis (UC), but newer endoscopic and histological indices could improve this. This study aimed to

00:00:00

Keeping CALM in Crohn’s Disease: An Exploration of...

Gastroenterology and Hepatology ·

2021/04/08

Guest: Xiaohong Wang, MD, PhD Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohn's Disease: A Post Hoc Analysis From the CALM Study Walter Reinisch, Remo Panaccione, Peter Bossuyt, Filip Baert, Alessandro Armuzzi, Xavier Hébuterne, Simon Travis, Silvio Danese, William J Sandborn, Stefan Schreiber, Sofie Berg, Qian Zhou, Kristina Kligys, Ezequiel Neimark, Ahmed A Suleiman, Geert D'Haens, Jean-Frederic Colombel Background: CALM was a randomized phase 3 trial in patients

00:00:00

Crohn’s & Colitis Congress 2021: The Future of IBD...

Gastroenterology and Hepatology ·

2021/02/22

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Siddharth Singh, MD Dr. Charles Turck is joined by Dr. Siddharth Singh from the University of California, San Diego, to discuss emerging therapies for inflammatory bowel disease, or IBD, and share some highlights from the session “The Future of IBD Treatments” from Crohn’s & Colitis Congress 2021.

00:00:00

Crohn’s & Colitis Congress 2021: Incorporating IBD...

Gastroenterology and Hepatology ·

2021/01/13

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Stephen Hanauer, MD Dr. Turck joins Dr. Stephen Hanauer of Northwestern University to discuss some of the highlights from his upcoming presentation at the 2021 Crohn’s & Colitis Congress, a Partnership of the Crohn’s and Colitis Foundation and the American Gastroenterological Association.

84 results

Gastroenterology and Hepatology

All Episodes

Similar Podcasts

Eye On The Sky

Vermont Public

Cienciaes.com

cienciaes.com

This Week in Virology

Vincent Racaniello

Hablando con Científicos - Cienciaes.com

cienciaes.com

The Elective Rotation: A Critical Care Hospital Pharmacy Podcast

Pharmacy Joe